▼Resmetirom (REZDIFFRA) gegen metabolische Dysfunktion-assoziierte Steatohepatitis (MASH) Das arznei-telegramm informiert - unabhängig. kritisch. anzeigenfrei.

#Resmetirom (REZDIFFRA) gegen metabolische Dysfunktion-assoziierte #Steatohepatitis (MASH)

Erstmals ist ein Mittel zur Behandlung der metabolischen Fettleberhepatitis im Handel, doch ein klinischer Nutzen ist bislang nicht nachgewiesen.

www.arznei-telegramm.com/de/6465/resm...

#Research
#Hic_5 promotes the progression of #nonalcoholic #steatohepatitis by regulating #hepatocellular fatty acid #metabolism through the #PTEN/PGE2/EP4 axis doi.org/10.1186/s435...

#NonalcoholicSteatohepatitis #HepaticStellateCell #hepatocytes

Discover the growing evidence for incretin-based therapies in #MASH, the potential mechanisms involved, common side effects, and what’s needed to finesse their use.

👉 buff.ly/0CRWkIE

#Steatohepatitis

JCI - A recurrent ACAA2 variant causes a dominant syndrome of lipodystrophy, lipomatosis, infantile steatohepatitis and hypoglycemia

A recurrent #ACAA2 variant causes a #dominant syndrome of #lipodystrophy, #lipomatosis, infantile #steatohepatitis and
#hypoglycemia
Per @rjdlab.bsky.social‬, "very few inborn errors of metabolism are inherited in a dominant fashion. These are zebras among zebras"!

🚨#August #Genes & #Immunity is out: www.nature.com/gene/volumes...
⏩READ ABT: #metabolism #CD4 #Tcells #NKcells #colorectal #cancer, #nonalcoholic #steatohepatitis, #breastcancer #macrophages, #Immunology #kidneycancer #uveal #melanoma #fulminant #myocarditis; #pyroptosis #arthritis!

https://www.nejm.org/doi/full/10.1056/NEJMoa2413258

Phase 3 Trial of #Semaglutide in #Metabolic Dysfunction–Associated #Steatohepatitis

In patients with #MASH and moderate or advanced #liver #fibrosis, once-weekly semaglutide at a dose of 2.4 mg improved liver steatohepatitis & fibrosis at 72 weeks
t.co/vfcgItgXpb

Macrophage inhibition in the alleviation of nonalcoholic steatohepatitis caused by bariatric surgery - Genes & Immunity Genes & Immunity - Macrophage inhibition in the alleviation of nonalcoholic steatohepatitis caused by bariatric surgery

🚨 #Research #Alert
#Macrophage inhibition in the alleviation of #nonalcoholic #steatohepatitis caused by #bariatric #surgery

#Genes & #Immunity @springernature.com www.nature.com/articles/s41...

The crucial function of gut microbiota on gut–liver repair
doi.org/10.1016/j.hl...
#microbiota #metabolic-associated #steatohepatitis (MASH) #inflammatory bowel disease (IBD) #gut–liver axis

Exploring the Booming Metabolic Dysfunction-Associated Steatohepatitis Market Growth in the US DelveInsight's report highlights key trends in the Metabolic Dysfunction-Associated Steatohepatitis market, projected to grow at a CAGR of 17.9% by 2034, with a focus on emerging therapies and market shares.

Exploring the Booming Metabolic Dysfunction-Associated Steatohepatitis Market Growth in the US #United_States #Las_Vegas #DelveInsight #Metabolic_Dysfunction #Steatohepatitis